Angiodynamics (ANGO) Total Non-Current Liabilities (2012 - 2026)
Angiodynamics' (ANGO) quarterly Total Non-Current Liabilities came in at $80.0 million in Q2 2026, little changed YoY from $80.3 million in Q2 2025, and up 13.33% on a QoQ basis from $70.6 million in Q1 2026.
Angiodynamics (ANGO) Total Non-Current Liabilities (2012 - 2026) Analysis & Trends
Angiodynamics (ANGO) has 15 years of Total Non-Current Liabilities data on file, last reported at $80.0 million in Q2 2026.
- Quarterly Total Non-Current Liabilities changed 0.3% year-over-year to $80.0 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $80.0 million (changed 0.3% YoY) and the FY2026 annual result came in at $80.0 million, changed 0.3% from the prior year.
- Total Non-Current Liabilities rose to $80.0 million in Q2 2026, from $70.6 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $149.8 million in Q2 2023 to a low of $61.7 million in Q3 2023.
- A 5-year average of $99.1 million and a median of $94.4 million in 2023 frame the typical range for Total Non-Current Liabilities.
- The widest YoY moves for Total Non-Current Liabilities: up 46.89% in 2023, down 54.41% in 2023.
- Tracing ANGO's Total Non-Current Liabilities over 5 years: stood at $141.2 million in 2022, then plunged by 32.15% to $95.8 million in 2023, then slipped by 2.99% to $92.9 million in 2024, then retreated by 17.9% to $76.3 million in 2025, then climbed by 4.9% to $80.0 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $80.0 million (Q2 2026), $70.6 million (Q1 2026), and $76.3 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 48.34 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 6.34 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 985.45 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 17.56 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 8.96 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 3.98 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.41 Bn |
| 10 | Angiodynamics | 655.49 Mn | 601.62 Mn | 46.77 Mn | 80.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 80.03 Mn |
| Feb 28, 2026 | 70.62 Mn |
| Nov 30, 2025 | 76.29 Mn |
| Aug 31, 2025 | 72.55 Mn |
| May 31, 2025 | 80.27 Mn |
| Feb 28, 2025 | 82.17 Mn |
| Nov 30, 2024 | 92.93 Mn |
| Aug 31, 2024 | 81.33 Mn |
| May 31, 2024 | 96.01 Mn |
| Feb 29, 2024 | 106.14 Mn |
| Nov 30, 2023 | 95.80 Mn |
| Aug 31, 2023 | 61.71 Mn |
| May 31, 2023 | 149.81 Mn |
| Feb 28, 2023 | 142.11 Mn |
| Nov 30, 2022 | 141.18 Mn |
| Aug 31, 2022 | 135.35 Mn |
| May 31, 2022 | 123.53 Mn |
| Feb 28, 2022 | 96.75 Mn |
| Nov 30, 2021 | 114.01 Mn |
| Aug 31, 2021 | 103.88 Mn |